211 related articles for article (PubMed ID: 6379879)
1. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies.
Jansen J; Falkenburg JH; Stepan DE; LeBien TW
Semin Hematol; 1984 Jul; 21(3):164-81. PubMed ID: 6379879
[No Abstract] [Full Text] [Related]
2. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
Freedman AS; Takvorian T; Nadler LM; Anderson KC; Sallan SE; Ritz J
Cancer Treat Res; 1988; 38():265-83. PubMed ID: 2908599
[No Abstract] [Full Text] [Related]
3. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
4. The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeys.
Gerritsen WR; Wagemaker G; Jonker M; Kenter MJ; Wielenga JJ; Hale G; Waldmann H; van Bekkum DW
Transplantation; 1988 Feb; 45(2):301-7. PubMed ID: 3278419
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of T-lymphocyte-depleted bone marrow between HLA-mismatched individuals.
Spruce WE; McMillan R; Miller W; Fox R; Carson D; Schwartz DB; Hartman GA; Renshaw LW; Beutler E
Transplantation; 1983 Oct; 36(4):369-72. PubMed ID: 6353702
[TBL] [Abstract][Full Text] [Related]
6. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
7. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
[TBL] [Abstract][Full Text] [Related]
8. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
9. The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.
Macintyre EA
Clin Haematol; 1986 Feb; 15(1):249-67. PubMed ID: 3516492
[No Abstract] [Full Text] [Related]
10. [The phenotypic characteristics of T-lymphocytes that interact with hematopoietic stem cells: the expression of the antigens Lyt-1, Lyt-2 and L3T4].
Man'ko VM; Osipova EIu; Rudneva TB; Blagonravova OL
Tsitologiia; 1992; 34(7):86-90. PubMed ID: 1475856
[TBL] [Abstract][Full Text] [Related]
11. Applicability of antimyeloid monoclonal antibodies (L4F3, 1G10) to autologous bone marrow transplantation for patients with acute myelogenous leukemia.
Takahashi M; Maruyama S; Moriyama Y; Shibata A
Transplant Proc; 1992 Feb; 24(1):416-8. PubMed ID: 1539334
[No Abstract] [Full Text] [Related]
12. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of the T-lymphocytes interacting with hematopoietic stem cells: the expression of Lyt-3 antigen].
Man'ko VM; Rudneva TB; Filatov AV; Kompaniets NA; Osipova EIu
Tsitologiia; 1986 Apr; 28(4):461-4. PubMed ID: 3087041
[TBL] [Abstract][Full Text] [Related]
14. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
Falkenburg JH; Fibbe WE; Veenhof WF; Koning F; van Eeden G; Voogt PJ; Jansen J
Exp Hematol; 1986 Feb; 14(2):101-7. PubMed ID: 2417877
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
Howell AL; Fogg-Leach M; Davis BH; Ball ED
Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies and immunotoxins in bone marrow transplantation: purging marrow of ALL or GVHD cells with preservation of stem cells.
Kersey JH; Vallera D; Ramsay N; Filipovich A; Youle R; Neville D; Stong R; LeBien T
Haematol Blood Transfus; 1985; 29():34-8. PubMed ID: 3896970
[No Abstract] [Full Text] [Related]
17. Perspectives of monoclonal antibodies in the acute leukaemias.
Hervé P; Wijdenes J; Racadot E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503
[No Abstract] [Full Text] [Related]
18. Characterization of antigenic determinants on human myeloid colony forming cells with monoclonal antibodies.
Greenberg P; Grossman M; Charron D; Levy R
Exp Hematol; 1981 Aug; 9(7):781-7. PubMed ID: 6172283
[TBL] [Abstract][Full Text] [Related]
19. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
20. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
